These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10376865)

  • 1. Compliance to estrogen treatment one to three years after hysterectomy and bilateral salpingooophorectomy. The cohort's lifestyle, knowledge of ERT, benefits etc.
    Hée P
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):534-9. PubMed ID: 10376865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of estrogen replacement therapy following hysterectomy with oophorectomy for endometriosis.
    Hickman TN; Namnoum AB; Hinton EL; Zacur HA; Rock JA
    Obstet Gynecol; 1998 May; 91(5 Pt 1):673-7. PubMed ID: 9572209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer.
    Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Aiduk C
    Gynecol Oncol; 1997 Jul; 66(1):103-7. PubMed ID: 9234929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perimenopausal androgen decline after oophorectomy does not influence sexuality or psychological well-being.
    Aziz A; Brännström M; Bergquist C; Silfverstolpe G
    Fertil Steril; 2005 Apr; 83(4):1021-8. PubMed ID: 15820815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian management during radical hysterectomy in the premenopausal patient.
    Parker M; Bosscher J; Barnhill D; Park R
    Obstet Gynecol; 1993 Aug; 82(2):187-90. PubMed ID: 8336862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women's use of hormone replacement therapy for relief of menopausal symptoms, for prevention of osteoporosis, and after hysterectomy.
    Griffiths F; Convery B
    Br J Gen Pract; 1995 Jul; 45(396):355-8. PubMed ID: 7612339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of hysterectomy and bilaterally salpingo-oophorectomy on sexual function in post-menopausal women.
    Celik H; Gurates B; Yavuz A; Nurkalem C; Hanay F; Kavak B
    Maturitas; 2008 Dec; 61(4):358-63. PubMed ID: 18977621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen replacement therapy in women with breast cancer: a survey of patient attitudes.
    Vassilopoulou-Sellin R; Zolinski C
    Am J Med Sci; 1992 Sep; 304(3):145-9. PubMed ID: 1476153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A general practice pilot audit study to assess advice and treatment offered to women following hysterectomy.
    Drew SV; Rowe R; Panay N; Studd JW
    Climacteric; 1999 Sep; 2(3):212-7. PubMed ID: 11910599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent hysterectomy at bilateral salpingo-oophorectomy: benefits, risks, and costs.
    Grover CM; Kuppermann M; Kahn JG; Washington AE
    Obstet Gynecol; 1996 Dec; 88(6):907-13. PubMed ID: 8942826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient sources of drug information and attitudes to their provision: a corticosteroid model.
    Trewin VF; Veitch GB
    Pharm World Sci; 2003 Oct; 25(5):191-6. PubMed ID: 14584224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of estrogen replacement in young women with Turner syndrome.
    Hanton L; Axelrod L; Bakalov V; Bondy CA
    J Womens Health (Larchmt); 2003 Dec; 12(10):971-7. PubMed ID: 14709185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of estrogen replacement therapy on estrogen receptor expression and immunoregulatory cytokine secretion in surgically induced menopausal women.
    Xia X; Zhang S; Yu Y; Zhao N; Liu R; Liu K; Chen X
    J Reprod Immunol; 2009 Jul; 81(1):89-96. PubMed ID: 19497624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistency with estrogen replacement therapy among hysterectomized women after the Women's Health Initiative study.
    Kyvernitakis I; Kostev K; Hars O; Albert US; Kalder M; Hadji P
    Climacteric; 2015; 18(6):826-34. PubMed ID: 26517429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen replacement therapy in the elderly.
    Paganini-Hill A
    Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in attitudes, knowledge and hormone replacement therapy use: a comparative study in two random samples with 6-year interval.
    Thunell L; Stadberg E; Milsom I; Mattsson LA
    Acta Obstet Gynecol Scand; 2005 Apr; 84(4):395-401. PubMed ID: 15762973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laryngeal cytological aspects in women with surgically induced menopause who were treated with transdermal estrogen replacement therapy.
    Caruso S; Roccasalva L; Sapienza G; Zappalá M; Nuciforo G; Biondi S
    Fertil Steril; 2000 Dec; 74(6):1073-9. PubMed ID: 11119730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of bilateral salpingo-oophorectomy at the time of hysterectomy on pelvic organ prolapse: results from the Women's Health Initiative trial.
    Shveiky D; Kudish BI; Iglesia CB; Park AJ; Sokol AI; Lehman AM; Shara N; Howard BV
    Menopause; 2015 May; 22(5):483-8. PubMed ID: 25423323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?
    Roy JA; Sawka CA; Pritchard KI
    J Clin Oncol; 1996 Mar; 14(3):997-1006. PubMed ID: 8622051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.